FDA schedules panel meeting on AquaBounty's biotech salmon

08/25/2010 | Los Angeles Times (tiered subscription model)

The FDA's Veterinary Medicine Advisory Committee will hold a meeting on Sept. 19 and 20 to evaluate scientific data and determine whether AquaBounty Technologies' biotech salmon should be approved for human consumption. The FDA also scheduled a public meeting for Sept. 21 to determine whether to label the product as being genetically modified.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Food & Beverage

Job Title Company Location
Executive Chef
University of Southern California
Los Angeles, CA
Director - Web Marketing
The Culinary Institute of America
Hyde Park, NY
Director of Food and Beverage Operations
The Culinary Institute of America
San Antonio, TX
Hospitality and Customer Service Instructor
The Culinary Institute of America
San Antonio, TX
Culinarians Wanted, Kitchen Management Training in NYC
Hillstone Restaurant Group
New York City, NY